Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05TDJ
|
||||
| Former ID |
DIB016493
|
||||
| Drug Name |
TS01
|
||||
| Indication | Stroke [ICD9: 434.91, 437.6, 453, 671.5, 671.9; ICD10:I61-I63, I80-I82] | Phase 1 | [1] | ||
| Target and Pathway | |||||
| Target(s) | C1 esterase | Target Info | Modulator | [2] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| Pertussis | |||||
| Staphylococcus aureus infection | |||||
| Systemic lupus erythematosus | |||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Complement Activation, Classical Pathway | |||||
| Human Complement System | |||||
| Complement cascade | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037017) | ||||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.